We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs

News   Apr 20, 2012

 
Idenix Pharmaceuticals Provides Update on Hepatitis C Clinical Development Programs
 
 
 

RELATED ARTICLES

The First Precision Medicine Clinical Trial for Dogs With Lung Cancer

News

A "ground-breaking" new study led by the Translational Genomics Research Institute (TGen) suggests that the HER2 gene that

same gene is the cause of lung cancer in many dogs. Their findings, published in the journal Clinical Cancer Research, offer novel avenues for precision medicine in dogs.

READ MORE

Lab-on-a-Chip Aids Search for Drugs to Prevent Blood Clots

News

A tiny lab the size of a postage stamp could be the next "big thing" in the search for safer anti-clotting drugs to prevent heart attacks and strokes.

READ MORE

$1.7 Million Grant to Study Potential Skin Cancer Treatment

News

Ohio University scientists have been awarded a five-year $1.7 million grant to advance research on a potential prevention and treatment for non-melanoma skin cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE